Acne cure rate in patients Hyperandrogenism with two drugs of Decuttane and CYPROTERONE COMPOUND .
Not Applicable
- Conditions
- Acne vulgaris.acne vulgaris
- Registration Number
- IRCT2013110315246N1
- Lead Sponsor
- Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
age between 14-45 years old; besides acne hirsutism (Ferriman & Gallwey score greater than or equal to 4) and Ludwing grade one or higher female androgenetic alopecia; absence of contraindications to treatment with tablets decuttane and CYPROTERONE COMPOUND based on questionnaire; not wanting to at least 9 months of pregnancy, or breast-feeding; individual patients signed a consent form
Exclusion criteria: drug allergy; pregnancy or lactation; uncooperative patient or patient's consent to continue reading.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of acne vulgaris lesions. Timepoint: Baseline, three months and one month after the end of treatment. Method of measurement: Indices are calculated based on the Total Acne lesion Count( TLC) and acne severity index (ASI) for each patient.
- Secondary Outcome Measures
Name Time Method Side effects of drug. Timepoint: Every 6 weeks. Method of measurement: clinical evaluation-liver function test and lipid profile.